BusinessBionano Genome Mapping Found to Be Superior to Existing Clinical Tests for the Identification of Pathogenic Structural Variants in Duchenne Muscular DystrophyBy Nasdaq OMXNov 1, 2017, 12:01 PM UTC
BusinessBeijing Grandomics Announces Intent to Use the Saphyr System for Molecular Diagnosis of Facioscapulohumeral Muscular Dystrophy (FSHD) in ChinaBy Nasdaq OMXOct 19, 2017, 6:01 PM UTC
BusinessGenoptix and Bionano Genomics Announce Strategic AllianceBy Nasdaq OMXJun 28, 2017, 12:00 PM UTC
